Protein kinase C beta inhibitor prevents diabetic peripheral neuropathy, but not histopathological abnormalities of retina in Spontaneously Diabetic Torii rat
- 28 September 2009
- journal article
- research article
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 11 (11) , 1084-1087
Abstract
Spontaneously Diabetic Torii (SDT) rat shows severe ocular complications such as tractional retinal detachment. In the present study, effect of protein kinase C beta (PKCβ) inhibitor JTT‐010 was evaluated to clarify the involvement of PKCβ in complications of SDT rat. SDT rats were administered JTT‐010 (10 or 50 mg/kg/day) for 48 weeks. SDT rats showed delayed oscillatory potentials in electroretinogram. Delayed motor nerve conduction velocity, decreased coefficients of variation of R–R intervals in electrocardiogram and thermal hypoalgesia were also observed. These functional disorders were prevented by administration of JTT‐010. Abnormal retinal vascular was formed and the optic disc was protruded in SDT rat; however, JTT‐010 did not prevent these hyperglycaemia‐induced retinal abnormalities. These findings indicate that PKCβ is intimately involved in diabetic complications; however, it seems that other factor(s) are primary contributors to histopathological abnormalities in retina. Therefore, PKCβ inhibitors require concurrent administration of antihyperglycaemic drugs to achieve maximum effect on diabetic complications.Keywords
This publication has 11 references indexed in Scilit:
- Stratified analyses for selecting appropriate target patients with diabetic peripheral neuropathy for long‐term treatment with an aldose reductase inhibitor, epalrestatDiabetic Medicine, 2008
- Effect of Ruboxistaurin in Patients With Diabetic Macular EdemaArchives of Ophthalmology (1950), 2007
- PKC - A target for treating diabetic complicationsDrugs of the Future, 2006
- Preventive effects of glycaemic control on ocular complications of Spontaneously Diabetic Torii ratDiabetes, Obesity and Metabolism, 2005
- Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C β-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trialClinical Therapeutics, 2005
- Novel protein kinase C‐β isoform selective inhibitor JTT‐010 ameliorates both hyper‐ and hypoalgesia in streptozotocin‐ induced diabetic ratsDiabetes, Obesity and Metabolism, 2004
- Neuropathy in diabetic mice overexpressing human aldose reductase and effects of aldose reductase inhibitorBrain, 2001
- A New Spontaneously Diabetic Non‐obese Torii Rat Strain With Severe Ocular ComplicationsJournal of Diabetes Research, 1999
- Amelioration of Vascular Dysfunctions in Diabetic Rats by an Oral PKC β InhibitorScience, 1996
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993